The immune response to leukemia is poorly understood. We postulated th
at nonmalignant T lymphocytes remaining within bone marrow from childr
en with newly diagnosed ALL could be involved in this immune response.
T lymphocytes which expressed gamma delta TCR comprised less than 1%
of ALL marrow cells. A preferential outgrowth of gamma delta T cells w
ithin the CD3 population was observed when marrow cells were cultured
with IL-2 alone or with stimulating feeder cells. These results, obtai
ned in a series of 14 patients with precursor B-ALL, were significantl
y different when compared with expansions from normal marrow cells. In
one patient, the clones established from the expanded population disp
layed different patterns of cytotoxicity against tumoral targets of th
e B cell lineage. Some clones expressing the TCR V delta 1 segment sho
wed cytotoxic activity against a cell line derived from a pre-B ALL wi
thout activity against a LAK-sensitive B cell line. Using PCR amplific
ation, one such clone was detected at high frequency, in the primary e
xpansion of ALL marrow cells. These results suggest a prior activation
in vivo of some gamma delta T cells by leukemic cells and provide som
e evidence on the role of these subsets in the immune response to leuk
emia.